Yuan-Chih Le

Title: Innovations of Yuan-Chih Le in Neurodegenerative Disorder Treatment

Introduction

Yuan-Chih Le is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations for treating neurodegenerative disorders. His innovative approach combines both sustained-release and immediate-release drugs to enhance therapeutic efficacy.

Latest Patents

Yuan-Chih Le holds a patent for an "Oral pH independent dosage formulation for treating neurodegenerative disorders." This formulation is designed to provide effective treatment for neurodegenerative conditions. It features a unique combination of memantine as a sustained-release drug and donepezil and/or memantine as immediate-release drugs. The formulation is characterized by its pH-independent dissolution profile of memantine across a pH range from about 1.0 to about 7.0, making it versatile for various gastrointestinal environments.

Career Highlights

Yuan-Chih Le is associated with Center Laboratories, Inc., where he continues to work on innovative pharmaceutical solutions. His research focuses on improving drug delivery systems to enhance patient outcomes in neurodegenerative disease management.

Collaborations

Yuan-Chih Le collaborates with esteemed colleagues, including Meng-Ju Lee and Shu-Hsien Chang. Their combined expertise contributes to the advancement of research and development in the pharmaceutical industry.

Conclusion

Yuan-Chih Le's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of neurodegenerative disorders. His contributions are paving the way for more effective therapeutic options in this critical area of medicine.